1. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer‐testis antigen XAGE‐1b (GAGED2a) in patients with non‐small cell lung cancer. (April 2014) Authors: Pandey, J. P.; Namboodiri, A. M.; Ohue, Y.; Oka, M.; Nakayama, E. Journal: Clinical and experimental immunology Issue: Volume 176:Number 1(2014:Apr.) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Higher levels of antibodies to the tumour‐associated antigen cyclin B1 in cancer‐free individuals than in patients with breast cancer. (October 2014) Authors: Pandey, J. P.; Kistner‐Griffin, E.; Namboodiri, A. M.; Iwasaki, M.; Kasuga, Y.; Hamada, G. S.; Tsugane, S. Journal: Clinical and experimental immunology Issue: Volume 178:Number 1(2014:Oct.) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. (4th February 2013) Authors: Pandey, J. P.; Namboodiri, A. M.; Kistner‐Griffin, E.; Iwasaki, M.; Kasuga, Y.; Hamada, G. S.; Tsugane, S. Journal: Clinical and experimental immunology Issue: Volume 171:Number 3(2013:Mar.) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗